Targeting the Hsp40/Hsp70 Chaperone Axis as a Novel Strategy to Treat Castration-Resistant Prostate Cancer

Journal: Cancer Research

Published: 2018-07-15

DOI: 10.1158/0008-5472.can-17-3728

Affiliations: 6

Authors: 17

Go to article
Institutions FC
NIH NCI Urologic Oncology Branch, United States of America (USA) 0.47
NIH NCI Developmental Therapeutics Branch, United States of America (USA) 0.18
Department of Molecular and Cellular Biology, BCM, United States of America (USA) 0.12
Stanford Division of Radiation and Cancer Biology, United States of America (USA) 0.12
UCSF Department of Pharmaceutical Chemistry, United States of America (USA) 0.06
UCSF Institute for Neurodegenerative Diseases (IND), United States of America (USA) 0.06

Return